Domenico Scala has been Chairman of the Board of Directors of BAK Economics AG since 1 January 2015.
He has been Chairman of the Board of Directors of Basilea Pharmaceutica AG since April 2016 and has been Chairman of the Board of Directors of Oettinger Davidoff AG since August 2017. He is also a member of the Bank Council of Basler Kantonalbank. In addition, Domenico Scala serves on the Healthcare Advisory Board of an equity investment and M&A company as well as on the boards of two private US biotech companies.
Scala studied economics at the University of Basel and completed management education programs at INSEAD and London Business School. He started his professional career at Nestlé and Panalpina. From 1995 to 2003 he held various management positions at Roche, most recently as Group Treasurer. From 2003 to 2007 Domenico Scala was CFO of Syngenta AG and from 2007 to 2011 CEO of Nobel Biocare AG. In 2004, he was elected Young Global Leader by the World Economic Forum (WEF). From May 2012 to May 2016 he was elected Chairman of the Audit and Compliance Committee of FIFA.